RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors
Clinical trial NCT05284968 · UNKNOWN
Trial details
- NCT number
- NCT05284968
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2023-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.